Liraglutide
Supports weight management and blood sugar control through appetite regulation. A well-established GLP-1 option.
This peptide is an FDA-approved drug product that can be legally prescribed by licensed clinicians.
The basics
- Generic Name
- liraglutide
- Brand Names
- Victoza, Saxenda
- Regulatory Status
- Prescribed by Doctors
- Therapeutic Areas
- Metabolic & Weight Management, Cardiovascular
- Prescribing Specialties
- Primary care, Endocrinology, Obesity medicine
Wellness Goals
What it does
Liraglutide is an FDA-approved medication that your doctor can prescribe. GLP-1 receptor agonist that increases insulin secretion, suppresses glucagon, and promotes satiety. Shares the GLP-1 mechanism class with semaglutide.
How it's taken
Daily subcutaneous injection
How people access it
Prescribed by a doctor and filled at a retail pharmacy. Available as Victoza (diabetes) or Saxenda (weight management). Requires daily injections unlike weekly semaglutide.
What doctors prescribe it for
- Glycemic control in type 2 diabetes and CV risk reduction (Victoza)
- Chronic weight management (Saxenda)
Clinicians may prescribe FDA-approved drugs for off-label uses based on their clinical judgment. Off-label indications have not undergone the same FDA review process as the labeled uses listed above.
How to know it's legit
You can independently verify the FDA-approval status of Liraglutide through these free, publicly available databases:
- DailyMed (dailymed.nlm.nih.gov) — Search for Victoza to find the current FDA-approved labeling, including indications, dosing, warnings, and contraindications.
- Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) — Search to find the original approval letter, review documents, and approval history.
- FDA Orange Book (orangebook.fda.gov) — Search for therapeutic equivalence evaluations and patent/exclusivity information.
Common Questions
Yes. Liraglutide (Victoza, Saxenda) is an FDA-approved drug product. It has undergone rigorous review of safety, efficacy, and manufacturing quality by the FDA. It can be legally prescribed by licensed clinicians for its approved indications.
Liraglutide is FDA-approved for: Glycemic control in type 2 diabetes and CV risk reduction (Victoza); Chronic weight management (Saxenda). Off-label use may be considered by clinicians on a case-by-case basis, but only the labeled indications have been reviewed and approved by the FDA.
You can verify the approval status of Liraglutide through several official FDA resources: DailyMed (dailymed.nlm.nih.gov) for current labeling, Drugs@FDA (accessdata.fda.gov/scripts/cder/daf/) for approval history, and the FDA Orange Book for therapeutic equivalence information. These are free, publicly available databases.
Want to learn more?
Explore how Liraglutide compares to other options, or dive deeper into how FDA approval works.
Explore All Peptides